Coloplast A/S
Last update: Mar 23, 2026 at 13:52
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Dividend Overview
Dividend Yield
5.39%
Annual Dividend
DKK 23.00
Frequency
Semi-Annual
Payout Ratio
129.94%
FCF Payout Ratio
174.61%
Stock Price
—
52-Week Range
— – —
Dividend Health Score
COLO.B.CO's dividend shows some areas that warrant monitoring. Strengths include a 9.0x interest coverage and 27.3% return on equity. Areas of concern: 129.9% earnings payout ratio and 174.6% fcf payout ratio. As a Dividend Aristocrat with 25+ consecutive years of increases, COLO.B.CO has a proven commitment to shareholders.
Based on 14 of 14 metrics
Payout & Coverage
WarningBalance Sheet
CautionProfitability
Very SafeDividend Track Record
Very SafeDividend History (2016–2025)
COLO.B.CO annual dividend per share and yield history
Earnings & Profitability
COLO.B.CO earnings per share and net profit margin
Key Dates
Next Ex-Dividend Date
December 5, 2025
Next Payment Date
—
Dividend Growth
3-Year Dividend CAGR
4.77%
5-Year Dividend CAGR
5.02%
10-Year Dividend CAGR
11.14%
3-Year Total Growth
15.00%
5-Year Total Growth
27.78%
10-Year Total Growth
187.50%
10
This company has increased its dividend for 25+ consecutive years.
Income Calculator
Frequently Asked Questions
What is COLO.B.CO's current dividend yield?
When is COLO.B.CO's next dividend payment date?
How much does COLO.B.CO pay in dividends per year?
Has COLO.B.CO been increasing its dividend?
Is COLO.B.CO's dividend safe?
How is COLO.B.CO's Dividend Health Score calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track COLO.B.CO Dividends with OnlyDividends
What will COLO.B.CO actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.